Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BSP:PFRM3's Cyclically Adjusted PB Ratio is ranked better than 84.78% of 92
companies
in the Medical Distribution industry
Industry Median: 1.135
vs BSP:PFRM3: 0.50
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Profarma Distribuidora De Produtos Farmaceuticos's adjusted book value per share data for the three months ended in Mar. 2026 was R$10.940. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$12.55 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Profarma Distribuidora De Produtos Farmaceuticos Cyclically Adjusted PB Ratio Related Terms
Profarma Distribuidora De Produtos Farmaceuticos Cyclically Adjusted PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Profarma Distribuidora De Produtos Farmaceuticos Cyclically Adjusted PB Ratio Chart
Profarma Distribuidora De Produtos Farmaceuticos Annual Data
BSP:PFRM3 vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison
For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profarma Distribuidora De Produtos Farmaceuticos Cyclically Adjusted PB Ratio vs Medical Distribution Industry
Profarma Distribuidora De Produtos Farmaceuticos Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 0.50 mean?
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a Cyclically Adjusted PB Ratio of 0.50 as of Jul. 29, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. This is 52% above median its historical median of 0.33. Over the past decade, Profarma Distribuidora De Produtos Farmaceuticos' Cyclically Adjusted PB Ratio has ranged from 0.18 to 0.72. According to the industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #14 out of 92 companies in the Medical Distribution industry, placing it in the top 15.2%.
Is Profarma Distribuidora De Produtos Farmaceuticos' Cyclically Adjusted PB Ratio too high?
Profarma Distribuidora De Produtos Farmaceuticos' current Cyclically Adjusted PB Ratio of 0.50 is 52% above median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 0.72. The Medical Distribution industry median Cyclically Adjusted PB Ratio is 1.14. Profarma Distribuidora De Produtos Farmaceuticos' value of 0.50 is 55.9% below this industry median. Based on the distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #14 out of 92 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' Cyclically Adjusted PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #14 out of 92 companies for Cyclically Adjusted PB Ratio. This places Profarma Distribuidora De Produtos Farmaceuticos in the top 15% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PB Ratio is 1.14. Profarma Distribuidora De Produtos Farmaceuticos' value of 0.50 is 55.9% below this benchmark. Historically, Profarma Distribuidora De Produtos Farmaceuticos' own Cyclically Adjusted PB Ratio has ranged from 0.18 to 0.72 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 1.14, Profarma Distribuidora De Produtos Farmaceuticos has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Distribution company?
The median Cyclically Adjusted PB Ratio among Medical Distribution companies is 1.14, based on 92 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profarma Distribuidora De Produtos Farmaceuticos's current Cyclically Adjusted PB Ratio of 0.50 is 55.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. For the Medical Distribution industry, the median Cyclically Adjusted PB Ratio is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profarma Distribuidora De Produtos Farmaceuticos's current Cyclically Adjusted PB Ratio is 0.50, which is 52% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.10, compared to a current price of R$6.25 — trading 22.8% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 0.50, which is 52% above median its 10-year median of 0.33 and 55.9% below the Medical Distribution industry median of 1.14. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current Cyclically Adjusted PB Ratio is 0.50 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued.
The current stock price of R$6.25 is trading 22.8% below its estimated GF Value™ of R$8.10.
GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.
Key valuation signals for BSP:PFRM3:
Cyclically Adjusted PB Ratio: 0.50 (52% above median its 10-year median of 0.33)
GF Value™: R$8.10 vs. price of R$6.25 (22.8% below fair value)
Industry Position: 55.9% below the Medical Distribution median (#14 of 92)
No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profarma Distribuidora De Produtos Farmaceuticos Business Description
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score
Get the complete analysis for BSP:PFRM3
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PFRM3 has been successfully added to your 
